WINNERS & LOSERS: Iofina falls as output weaker than expected
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More
| Price | 0.115p on 19-10-2026 at 18:35:13 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.13p |
| Sell | 0.10p |
| Last Trade: | Sell 170,686.00 at 0.10p |
| Day's Volume: | 4,732,111 |
| Last Close: | 0.115p |
| Open: | 0.115p |
| ISIN: | GB00BMD6PM55 |
| Day's Range | 0.115p - 0.115p |
| 52wk Range: | 0.08p - 0.18p |
| Market Capitalisation: | £1.70m |
| VWAP: | 0.10656p |
| Shares in Issue: | 1.48b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Gunsynd (GUN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 170,686 | 0.10p | Ordinary |
15:15:48 - 19-Oct-26 |
| Buy* | 884 | 0.13p | SI Trade |
15:14:11 - 19-Oct-26 |
| Buy* | 2,307 | 0.13p | SI Trade |
15:14:11 - 19-Oct-26 |
| Buy* | 15,384 | 0.13p | SI Trade |
15:14:11 - 19-Oct-26 |
| Sell* | 1,022 | 0.10p | SI Trade |
15:14:11 - 19-Oct-26 |
| Sell* | 1,500 | 0.10p | SI Trade |
15:14:11 - 19-Oct-26 |
| Sell* | 1,006 | 0.10p | SI Trade |
15:14:11 - 19-Oct-26 |
| Sell* | 20,000 | 0.10p | SI Trade |
15:14:11 - 19-Oct-26 |
| Sell* | 3,291 | 0.10p | SI Trade |
15:14:11 - 19-Oct-26 |
| Sell* | 10,000 | 0.10p | SI Trade |
15:14:11 - 19-Oct-26 |
Gunsynd (GUN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Oct 2026 2:13 pm | RNS | Re Share Price Movement |
| 15th Oct 2026 3:10 pm | RNS | Issue of Equity |
| 13th Oct 2026 7:29 am | RNS | Director/PDMR Shareholding |
| 12th Oct 2026 7:00 am | RNS | Conversion to Operating Company, Cap Reorg & GM |
| 8th Oct 2026 3:09 pm | RNS | Holding(s) in Company |
| 7th Oct 2026 7:00 am | RNS | Holding(s) in Company |
| 6th Oct 2026 7:00 am | RNS | Holding(s) in Company |
| 25th Aug 2026 9:21 am | RNS | Update on Eagle Lake Project |
| 31st Jul 2026 2:58 pm | RNS | Relinquishment of Bear Twit & Hornby Bay Projects |
| 24th Jul 2026 7:00 am | RNS | New Corporate Presentation |